These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6170952)

  • 41. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 43. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
    J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
    Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
    Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mediastinal growing teratoma syndrome.
    Afifi HY; Bosl GJ; Burt ME
    Ann Thorac Surg; 1997 Aug; 64(2):359-62. PubMed ID: 9262575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Histopathology of testicular germ cell tumors].
    Morinaga S; Sasano N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Germ cell testicular tumors. Three therapeutic periods].
    Fargeot P
    Bull Cancer; 1990; 77(4):331-9. PubMed ID: 1693863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
    Jaeger N; Vahlensieck W
    Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
    Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
    Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
    Kuczyk MA; Bokemeyer C; Fichna B; Truss M; Schmoll HJ; Jonas U
    Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Schatte EC; Lerner SP
    J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
    Lange PH; Hakala TR; Fraley EE
    Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.